These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19330195)

  • 1. [Molecular imaging of cerebral blood flow and metabolism with SPET and PET in principal dementias].
    Gerasimou G; Bostantjopoulou S; Gotzamani-Psarrakou A
    Hell J Nucl Med; 2009; 12(1):79-83. PubMed ID: 19330195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emission tomography in dementia.
    Pakrasi S; O'Brien JT
    Nucl Med Commun; 2005 Mar; 26(3):189-96. PubMed ID: 15722899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index.
    Döbert N; Pantel J; Frölich L; Hamscho N; Menzel C; Grünwald F
    Dement Geriatr Cogn Disord; 2005; 20(2-3):63-70. PubMed ID: 15908747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography imaging in dementia.
    Herholz K; Carter SF; Jones M
    Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
    Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
    Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.
    Silverman DH
    J Nucl Med; 2004 Apr; 45(4):594-607. PubMed ID: 15073255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging (SPECT and PET) in the evaluation of patients with movement disorders.
    Gerasimou GP; Aggelopoulou TC; Costa DC; Gotzamani-Psarrakou A
    Nucl Med Rev Cent East Eur; 2006; 9(2):147-53. PubMed ID: 17304479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of cerebral blood flow in frontotemporal lobar degeneration and Alzheimer's disease.
    Nagao M; Sugawara Y; Ikeda M; Fukuhara R; Hokoishi K; Murase K; Mochizuki T; Miki H; Kikuchi T
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):162-8. PubMed ID: 15129697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography and single-photon emission computed tomography brain imaging in the evaluation of dementia.
    Van Heertum RL; Tikofsky RS
    Semin Nucl Med; 2003 Jan; 33(1):77-85. PubMed ID: 12605358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
    Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Image analysis in patients with dementia].
    Tamaki N
    Hokkaido Igaku Zasshi; 1996 May; 71(3):303-7. PubMed ID: 8752524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain FDG PET and the diagnosis of dementia.
    Shivamurthy VK; Tahari AK; Marcus C; Subramaniam RM
    AJR Am J Roentgenol; 2015 Jan; 204(1):W76-85. PubMed ID: 25539279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.
    Derejko M; Sławek J; Wieczorek D; Brockhuis B; Dubaniewicz M; Lass P
    Nucl Med Commun; 2006 Dec; 27(12):945-51. PubMed ID: 17088679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET imaging in patients with pathologically verified dementia.
    Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
    J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging of neurotransmission and brain receptors in dementia.
    Pappatà S; Salvatore E; Postiglione A
    J Neuroimaging; 2008 Apr; 18(2):111-24. PubMed ID: 18380693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomographic study in Alzheimer's disease and Pick's disease.
    Salmon E; Franck G
    Arch Gerontol Geriatr Suppl; 1989; 1():241-7. PubMed ID: 2787995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies.
    Devous MD
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1685-96. PubMed ID: 12458405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regions of interest-based discriminant analysis of DaTSCAN SPECT and FDG-PET for the classification of dementia.
    Garibotto V; Montandon ML; Viaud CT; Allaoua M; Assal F; Burkhard PR; Ratib O; Zaidi H
    Clin Nucl Med; 2013 Mar; 38(3):e112-7. PubMed ID: 23357822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.